3,6-DIHYDROXYXANTHONE manufacturers
- Euxanthone
-
- $195.00 / 1mg
-
2025-07-17
- CAS:529-61-3
- Min. Order:
- Purity: 98%
- Supply Ability: 10g
|
| | 3,6-DIHYDROXYXANTHONE Basic information |
| Product Name: | 3,6-DIHYDROXYXANTHONE | | Synonyms: | 3,6-DIHYDROXYXANTHONE;1,7-DIHYDROXYXANTHONE;1,7-Dihydroxy-9H-xanthen-9-one;Eyxanthone;9H-Xanthen-9-one, 1,7-dihydroxy-;IFLAB-BB F0349-4255 | | CAS: | 529-61-3 | | MF: | C13H8O4 | | MW: | 228.2 | | EINECS: | | | Product Categories: | | | Mol File: | 529-61-3.mol |  |
| | 3,6-DIHYDROXYXANTHONE Chemical Properties |
| storage temp. | 2-8°C | | solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | | form | powder | | color | Yellow |
| | 3,6-DIHYDROXYXANTHONE Usage And Synthesis |
| Uses | Euxanthone, a xanthone derivative, attenuates Aβ1-42-induced oxidative stress and apoptosis by triggering autophagy. Euxanthone exhibits anti-neoplastic and neuroprotective activities[1][2][3]. | | Definition | ChEBI: A member of the class of xanthones that is 9H-xanthene substituted by hydroxy group at positions 1 and 7 and an oxo group at position 9. It has been isolated from Cratoxylum cochinchinense. | | Synthesis Reference(s) | Synthetic Communications, 19, p. 1641, 1989 DOI: 10.1080/00397918908051061 | | in vivo | Euxanthone (40-80 mg/kg) could significantly decrease the number of metastatic nodules in lung tissue in a pulmonary metastasis model[1].
Euxanthone (30-60 mg/kg; p.o.;once a day; for 7 days) treatment normalized Bnip3, Beclin1, Pink1, Parkin, p53, Bax, caspase-3, and LC3 II/I in bearing bilateral common carotid artery occlusion (BCCAO). Euxanthone modulates mitophagy and apoptosis induces by mitochondrial stress mediated by mitochondrial fragmentation[2]. | Animal Model: | Forty male ICR mice (20 g) induced cerebral ischemia and reperfusion[2] | | Dosage: | 30 mg/kg, 60 mg/kg | | Administration: | p.o.;once a day; for 7 days | | Result: | Markedly attenuated BCCAO triggered mitochondrial stress and related breakdown. |
| | References | [1] Xiaodong Chen, et al. Euxanthone Impairs the Metastatic Potential of Osteosarcoma by Reducing COX-2 Expression. Anat Rec (Hoboken). 2019 Aug;302(8):1399-1408. DOI:10.1002/ar.23992
[2] Wei Sun, et al. Euxanthone improves cognitive impairment by attenuating mitochondrial fragmentation and suppressing oxidative stress. Cent Eur J Immunol. 2021;46(4):446-455. DOI:10.5114/ceji.2021.111444
[3] aicheng Yuan, et al. Euxanthone Attenuates Aβ1-42-Induced Oxidative Stress and Apoptosis by Triggering Autophagy. J Mol Neurosci. 2018 Dec;66(4):512-523. DOI:10.1007/s12031-018-1175-2 |
| | 3,6-DIHYDROXYXANTHONE Preparation Products And Raw materials |
|